NanoViricides, Inc.
Hedge Funds Holdings
Last updated:
NanoViricides, Inc.‘s stocks are currently a part of 19 hedge funds’ portfolios, which represents 3.63% of the total amount of its stocks outstanding. This makes up a total of 421.53K shares of NanoViricides, Inc.. Compared to the previous quarter, the number fell by -69.08% or -941.84K shares fewer. As for the holding position changes, 15.79% (3) of current hedge fund investors increased the number of shares held, 21.05% (4) of current holders sold a part of the shares held, and 10.53% (2) closed the holdings completely. 4 hedge funds are new holders of NanoViricides, Inc. stock in Q1 2023, it is 21.05% of total holders.
Hedge funds holding NanoViricides (Q2 2018 – Q1 2023)
| Q2 2018 | 34 |
|---|---|
| Q3 2018 | 36 |
| Q4 2018 | 33 |
| Q1 2019 | 32 |
| Q2 2019 | 30 |
| Q3 2019 | 11 |
| Q4 2019 | 12 |
| Q1 2020 | 21 |
| Q2 2020 | 21 |
| Q3 2020 | 30 |
| Q4 2020 | 22 |
| Q1 2021 | 28 |
| Q2 2021 | 22 |
| Q3 2021 | 24 |
| Q4 2021 | 22 |
| Q1 2022 | 19 |
| Q2 2022 | 18 |
| Q3 2022 | 24 |
| Q4 2022 | 28 |
| Q1 2023 | 19 |
Hedge funds changes in NanoViricides positions (Q2 2018 – Q1 2023)
| Q2 2018 | 3 | 6 | 4 | 3 | 18 |
|---|---|---|---|---|---|
| Q3 2018 | 4 | 3 | 10 | 2 | 17 |
| Q4 2018 | 4 | 6 | 5 | 7 | 11 |
| Q1 2019 | 6 | 5 | 2 | 7 | 12 |
| Q2 2019 | 2 | 3 | 6 | 4 | 15 |
| Q3 2019 | 11 | 0 | 0 | 30 | -30 |
| Q4 2019 | 2 | 5 | 2 | 0 | 3 |
| Q1 2020 | 12 | 4 | 2 | 4 | -1 |
| Q2 2020 | 4 | 5 | 3 | 4 | 5 |
| Q3 2020 | 14 | 3 | 7 | 5 | 1 |
| Q4 2020 | 5 | 4 | 6 | 13 | -6 |
| Q1 2021 | 8 | 10 | 4 | 2 | 4 |
| Q2 2021 | 2 | 6 | 7 | 8 | -1 |
| Q3 2021 | 5 | 5 | 7 | 3 | 4 |
| Q4 2021 | 4 | 5 | 5 | 6 | 2 |
| Q1 2022 | 2 | 3 | 3 | 5 | 6 |
| Q2 2022 | 2 | 2 | 6 | 3 | 5 |
| Q3 2022 | 9 | 3 | 3 | 3 | 6 |
| Q4 2022 | 8 | 6 | 6 | 4 | 4 |
| Q1 2023 | 4 | 3 | 4 | 2 | 6 |
Hedge funds changes in NanoViricides stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 217,000 | 42,000 |
| Q4 2020 | 65,000 | 4,000 |
| Q1 2021 | 239,000 | 395,000 |
| Q2 2021 | 332,000 | 117,000 |
| Q3 2021 | 815,000 | 332,000 |
| Q4 2021 | 293,000 | 163,000 |
| Q1 2022 | 74,000 | 4,000 |
| Q2 2022 | 37,000 | 2,000 |
| Q3 2022 | 516,000 | 126,000 |
| Q4 2022 | 312,243 | 107,448 |
| Q1 2023 | 0 | 0 |